Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
2
×
fda
gene therapy
2
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sarepta therapeutics
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
allergan
alnylam pharmaceuticals
ambys medicines
amgen
amicus therapeutics
ampio pharmaceuticals
anemia
angelman syndrome
What
bio
drugs
2
×
fda
news
2
×
roundup
aren’t
august
biotech
busy
days
decisions
developers
devices
drug
gene
help
imminent
legacy
long
medicare
moves
nods
noteworthy
opioid
past
patients
prices
regulatory
road
rulings
sarepta’s
separate
seven
shkreli’s
slow
stumble
suits
tends
therapy
they’ll
Language
unset
Current search:
xconomy.com
×
drugs
×
" boston blog main "
×
news
×
" detroit top stories "
×
" gene therapy "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More